Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Psychosis & schizophrenia spectrum stories

Oct 30, 2026

UCSF launches trial of wearable ultrasound device to treat schizophrenia hallucinations

The University of California, San Francisco opened the MESSI-LEO Phase 1 trial on October 30, testing a wearable 128-element ultrasound headband that targets the caudate region of the brain to reduce auditory hallucinations in schizophrenia patients. The noninvasive treatment addresses persistent hallucinations that affect approximately 40% of patients despite antipsychotic medications.

Oct 30, 2026·2 sources
00
Oct 22, 2026

Study finds most people carry high genetic risk for three common diseases

University of Exeter researchers have characterized the 'average' human genome for the first time, revealing that most people carry high genetic risk for around three of 28 common conditions, including diabetes, cardiovascular disease, and schizophrenia, though this does not mean they are destined to become ill.

Oct 22, 2026·3 sources
00

McGill study links multiple schizophrenia symptoms to single brain signal

A new imaging study published in Science Advances has identified a single brain signal that may explain several distinct symptoms of schizophrenia, including altered perception, behavior, and speech patterns. The research suggests these seemingly separate problems may share a common neurological basis.

Oct 22, 2026·2 sources
00
Oct 14, 2026

GLP-1 drugs reduce psychiatric hospital visits in schizophrenia patients with diabetes

A large US health records study found that people with schizophrenia taking GLP-1 drugs for diabetes had fewer psychiatric relapses and hospital admissions, suggesting potential mental health benefits beyond metabolic effects.

Oct 14, 2026·2 sources
00
Oct 12, 2026

Cannabis-related psychosis hospitalizations rise sharply in Victoria, Monash University study finds

New research from Monash University published in Addiction reveals a sharp increase in cannabis-related hospital admissions across Victoria over the past decade, raising concerns about cannabis-related psychosis and the growing burden on the state's healthcare system.

Oct 12, 2026·1 source
00
Oct 8, 2026

FDA flags four deaths in Newron's schizophrenia drug studies

The FDA identified four deaths among patients treated with Newron Pharmaceuticals' experimental schizophrenia drug evenamide in feedback following the agency's earlier decision to place the trial on hold.

Oct 8, 2026·3 sources
00
Oct 7, 2026

FDA clears Motivista digital therapeutic for negative symptoms of schizophrenia

The FDA has granted 510(k) clearance to Motivista, a prescription digital therapeutic developed by Click Therapeutics for adults with negative symptoms of schizophrenia. The treatment is cleared as an adjunct to clinician-managed outpatient care, addressing symptoms that current medications targeting hallucinations and delusions do not effectively treat.

Oct 7, 2026·3 sources
00
Aug 15, 2026

Postpartum psychosis gains attention following Lindsay Clancy murder trial

The high-profile murder trial of Lindsay Clancy has brought postpartum psychosis into the spotlight. Women who have experienced the condition and medical professionals are calling for more research and understanding of this difficult mental illness.

Aug 15, 2026·2 sources
00
May 11, 2026

ChatGPT Free Version Shows 26x Higher Rate of Inappropriate Responses to Psychotic Delusions

Research published shows that ChatGPT's free version is 26 times more likely to respond inappropriately to psychotic delusions compared to paid versions, raising concerns about AI safety in mental health contexts and the disparity between free and premium AI services.

May 11, 2026·1 source
00

Top claims

  • ▪The MESSI-LEO trial led by Dr. Karuna Subramaniam will enroll up to 12 participants between ages 18 and 64 for five daily active ultrasound sessions targeting the caudate paired with five sham sessions.
  • ▪The ATTN201 wearable headband built by Attune Neurosciences uses 128 transducer elements operating at 500 kilohertz to steer acoustic energy 65 millimeters deep to the caudate head.
  • ▪The MESSI-LEO trial at the University of California San Francisco is funded by the Focused Ultrasound Foundation under grant 1685505.

Subtopics

Mental Health & Wellbeing5Mental health3Neurodiversity & Cognitive Function3Neuroscience2Addiction & recovery1AI assistants & chatbots1AI bias & fairness1AI ethics1AI safety & social impact1Biomedical engineering1Cardiovascular diseases1Chronic disease1Clinical genomics1Clinical trials1Diagnostic imaging1Genetic testing1Genomics1GLP-1 receptor agonists1Healthcare technology1Medical innovation1Medical research1Metabolic health1OpenAI1Personalized medicine1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories